NCT07696468

Brief Summary

Small incision lenticule extraction (SMILE) is a commonly used corneal refractive procedure for correcting myopia and myopic astigmatism. During astigmatism correction, eye rotation between the upright examination position and the supine surgical position may affect the alignment of the astigmatic treatment axis and may contribute to residual astigmatism after surgery. Manual limbal marking is a commonly used method to guide cyclotorsion adjustment during refractive surgery. OcuLign is an assisted cyclotorsion control function of the VISUMAX 800 platform that helps identify ocular rotation and guide axis alignment during SMILE. However, direct clinical evidence comparing OcuLign-assisted cyclotorsion control with manual limbal marking during SMILE is limited. This study is a single-center, prospective, randomized, masked, contralateral-eye non-inferiority trial. Adults aged 18 to 40 years with stable myopia and astigmatism who plan to undergo bilateral SMILE surgery will be enrolled. In each participant, one eye will receive SMILE with OcuLign-assisted cyclotorsion control, and the fellow eye will receive SMILE with manual limbal marking-guided cyclotorsion adjustment. The treatment assigned to the right eye will be determined by randomization. The primary objective is to compare residual refractive astigmatism at 3 months after surgery between the two methods. Secondary outcomes include visual acuity, refractive predictability and stability, astigmatism vector analysis, higher-order aberrations, contrast sensitivity, patient-reported quality of vision, overall satisfaction, and safety outcomes. Participants will be followed for approximately 6 months after surgery.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
11mo left

Started Jul 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
Jul 2026Jun 2027

First Submitted

Initial submission to the registry

July 6, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 10, 2026

Completed
3 days until next milestone

Study Start

First participant enrolled

July 13, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

July 15, 2026

Status Verified

July 1, 2026

Enrollment Period

12 months

First QC Date

July 6, 2026

Last Update Submit

July 13, 2026

Conditions

Keywords

myopiaSMILEVisuMax 800Cyclotorsion

Outcome Measures

Primary Outcomes (1)

  • Residual refractive astigmatism

    Residual refractive astigmatism will be measured as the absolute manifest cylinder power in diopters at 3 months after SMILE. The primary analysis will compare residual refractive astigmatism between eyes treated with OcuLign-assisted cyclotorsion control and eyes treated with manual limbal marking-guided cyclotorsion adjustment to evaluate non-inferiority.

    3 months after surgery

Secondary Outcomes (10)

  • Astigmatic correction predictability

    1 month, 3 months, and 6 months after surgery

  • Astigmatic Correction Assessed by Alpins Vector Analysis

    3 months after surgery

  • Visual acuity

    1 month, 3 months, and 6 months after surgery

  • Manifest refraction

    1 month, 3 months, and 6 months after surgery

  • Refractive accuracy

    1 month, 3 months, and 6 months after surgery

  • +5 more secondary outcomes

Study Arms (2)

OcuLign-Assisted Cyclotorsion Control

EXPERIMENTAL

One eye of each participant will undergo SMILE using OcuLign-assisted cyclotorsion control on the VISUMAX 800 platform. OcuLign will be used intraoperatively to assist in identifying ocular rotation and guiding astigmatic axis alignment. Apart from the cyclotorsion adjustment method, the surgical parameters, lenticule design, suction procedure, postoperative medication, and follow-up schedule will be the same as those used for the fellow eye.

Procedure: Device-assisted cyclotorsion control during SMILE

Manual Limbal Marking-Guided Adjustment

ACTIVE COMPARATOR

The fellow eye of each participant will undergo SMILE using manual limbal marking-guided cyclotorsion adjustment. Limbal reference marks will be made in the upright preoperative position, and intraoperative axis alignment will be manually adjusted according to the marks and the surgical reference direction. Apart from the cyclotorsion adjustment method, the surgical parameters, surgical procedure, postoperative medication, and follow-up schedule will be the same as those used for the contralateral eye.

Procedure: Manual limbal marking-guided cyclotorsion adjustment during SMILE

Interventions

One eye of each participant will undergo SMILE using device-assisted cyclotorsion control with the OcuLign function of the VISUMAX 800 platform. During surgery, OcuLign will assist in identifying ocular rotation and guiding astigmatic axis alignment. Apart from the cyclotorsion adjustment method, the surgical parameters, lenticule design, suction procedure, postoperative medication, and follow-up schedule will be the same as those used for the fellow eye.

Also known as: OcuLign-assisted cyclotorsion control, VISUMAX 800 OcuLign
OcuLign-Assisted Cyclotorsion Control

The fellow eye of each participant will undergo SMILE using manual limbal marking-guided cyclotorsion adjustment. Limbal reference marks will be made in the upright preoperative position, and intraoperative axis alignment will be manually adjusted according to the limbal marks and the surgical reference direction. Apart from the cyclotorsion adjustment method, the surgical parameters, surgical procedure, postoperative medication, and follow-up schedule will be the same as those used for the contralateral eye.

Manual Limbal Marking-Guided Adjustment

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age range: 18 - 40 years old. Patients with myopic astigmatism and stable refractive status for \>= 1 year.
  • Normal corneal morphology in both eyes, with corneal thickness and other ocular parameters meeting the requirements for SMILE surgery.
  • Preoperative corrected distance visual acuity (CDVA) \>= 1.0 in both eyes.
  • Manifest refractive cylinder \>= 0.75 D in both eyes, with an interocular difference in absolute cylinder power \<= 1.00 D.
  • Both eyes can provide reliable preoperative upright-position image information required for astigmatic axis recognition, and are judged by the investigator to meet the requirements for OcuLign cyclotorsion recognition and axis alignment on the VISUMAX 800 platform.
  • Voluntary to undergo bilateral SMILE surgery on the VISUMAX 800 platform, understanding the random eye-assignment scheme and signing the informed consent form.

You may not qualify if:

  • History of prior ocular surgery, significant ocular trauma, or presence of ocular diseases that may affect the safety of refractive surgery or the interpretation of study outcomes.
  • Irregular astigmatism or poor repeatability of bilateral astigmatism measurements, making reliable astigmatic axis analysis impossible.
  • Presence of strabismus, nystagmus, significant binocular vision abnormality, or any condition that may affect fixation or cooperation during examinations.
  • Severe systemic diseases that may affect ocular healing or surgical safety.
  • Females who are pregnant or lactating.
  • Inability to complete the required postoperative follow-up visits or questionnaire assessments.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan Ophthalmic Center

Guangzhou, Guangdong, 510060, China

Location

Related Publications (3)

  • Chen P, Ye Y, Yu N, Zhang X, He J, Zheng H, Wei H, Zhuang J, Yu K. Comparison of Small Incision Lenticule Extraction Surgery With and Without Cyclotorsion Error Correction for Patients With Astigmatism. Cornea. 2019 Jun;38(6):723-729. doi: 10.1097/ICO.0000000000001937.

    PMID: 30950894BACKGROUND
  • Wang B, Wang Y, Zhang J. Comparison of astigmatic correction with and without limbal marking during small-incision lenticule extraction. J Cataract Refract Surg. 2022 Aug 1;48(8):924-928. doi: 10.1097/j.jcrs.0000000000000889.

    PMID: 35067664BACKGROUND
  • Yang X, Liu Y, Xiao K, Song Q, Xu Y, Li J, Zhou Y. Effect of Cyclotorsion Compensation in Small Incision Lenticule Extraction Surgery for the Correction of Myopic Astigmatism: A Systematic Review and Meta-Analysis. Ophthalmol Ther. 2024 May;13(5):1271-1288. doi: 10.1007/s40123-024-00921-2. Epub 2024 Mar 18.

    PMID: 38498276BACKGROUND

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 6, 2026

First Posted

July 10, 2026

Study Start

July 13, 2026

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

June 30, 2027

Last Updated

July 15, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations